suppressor genes using large collections of RNA inter- well-known tumor suppressor gene TGFBR2, which enthe human genome to uncover two novel tumor supcodes the type II receptor for TGF-β. It is clearly pospressor genes. REST is a transcriptional repressor sible that this screen might identify genes that can act that silences neuron-specific gene expression, and to limit anchorage-independent growth in this particular PITX1 is a homeodomain transcription factor that proartificial cell system but which may never contribute to motes the expression of a negative regulator of Ras.
should be the targets of therapeutic intervention. Some
The use of RNA interference libraries targeting whole genomes has become a standard tool for the investigaof the more notorious critics of mouse tumor models tion of biological processes in worms and flies, but to might start thinking about lowering their collective date this methodology has not achieved any notable voices.
advances in mammalian systems, although some successes have been achieved with smaller, more focused Anton Berns collections (Downward, 2004 sible that this screen might identify genes that can act that silences neuron-specific gene expression, and to limit anchorage-independent growth in this particular PITX1 is a homeodomain transcription factor that proartificial cell system but which may never contribute to motes the expression of a negative regulator of Ras.
human tumorigenesis. However, array-based comparative genomic hybridization was used to show that two of these genes, TGFBR2 and REST, are deleted at a in their screen, a couple of which had previously been implicated as possible tumor suppressors. They consignificant frequency in human tumors. Evidence of deletions in the region of chromosome 4 where REST is centrated, however, on the homeodomain transcription factor PITX1. Knockdown of this gene allows fibrolocated were found in about a third of human tumors examined, although many other genes share this locablasts to grow in an anchorage-independent manner. The mechanism appears to involve constitutive activation. Microdeletions affecting REST were found in two colon cancers, plus evidence of a point mutation resulttion of the Ras signaling pathways at the level of GTP loading onto Ras itself, suggesting that PITX1 might ing in a dominant-negative form of REST in the wellstudied colon cancer cell line DLD-1, which also bears control the expression of one of the negative regulators of Ras of the GTPase-activating protein (GAP) family. an activating KRAS mutation. While this evidence certainly falls short of proof that REST is a significant huAn analysis of the sequences of the promoters of the eight human genes encoding Ras GAPs led them to man tumor suppressor gene, it definitely makes it a very good candidate for further investigation.
concentrate on RASAL1, a calcium-sensitive member of the family (Walker et al., 2004 ). PITX1 directly con-REST encodes a transcriptional repressor that silences the expression of neuronal-specific genes, introls the expression of RASAL1, with the reduction in GAP activity when PITX1 and consequently RASAL1 cluding neurotrophins, in nonneuronal tissues (Chong et al., 1995) . A plausible explanation for its role as a expression is lost being sufficient to induce the activation of endogenous wild-type Ras proteins within the tumor suppressor could be that its deletion allows expression of genes involved in promoting neuronal prolifcell (see Figure 1B) . Loss of PITX1 thus has the potential to have a similar effect to mutation of RAS genes in eration in epithelial tissues. While the exact mechanism here remains to be determined, loss of REST can result terms of activation of downstream Ras effector pathways. How good is the evidence that PITX1 is a tumor supin inappropriate expression of neurotrophins, such as BDNF, or their receptors, such as TrkC, which could pressor gene in human cancer? There is certainly precedent for the disregulation of Ras GAPs in human candrive transformation via activation of phosphatidylinositol 3-kinase (PI 3-kinase) and other Ras-dependent cer from type I neurofibromatosis, an inherited disorder characterized by high tumor incidence caused by depathways (see Figure 1A) These two studies highlight the power of selective screens using vector-based RNA interference libraries to uncover important novel players in human cancer. Two important mechanisms of carcinogenesis are highlighted: loss of suppression of neurotrophic genes in nonneuronal tissue and loss of expression of negative regulators of Ras. The prospects for gaining many more insights into the process of carcinogenesis using these technologies now look bright. 
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